ESG at Merck

ESG at Merck

For more than a century, Merck has been inventing medicines and vaccines for the world’s most challenging diseases. And today we’re continuing to invent new approaches that save and improve lives so that people can positively contribute to a healthier and more hopeful world.

Our environmental, social and governance (ESG) approach is aligned with the company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and wellbeing, developing and rewarding our employees, protecting the environment, and operating with the highest standards of ethics and transparency.

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.

Visit our website to learn more about our approach to ESG at Merck.

Content from this campaign

Merck Partners with INROADS to Launch College Links
Merck hosted the next generation of talent recently when a group of high school students toured the company’s Kenilworth site as part of the INROADS College Links program. Merck partnered with INROADS, an international nonprofit organization that prepares talented, diverse youth for corporate and community leadership, to launch College Links in Newark, New Jersey earlier this year....
Jul 16, 2019 12:10 PM ET
Merck Earns 2019 Energy Star Partner of the Year – Sustained Excellence Award​
Merck is proud to announce that it received the 2019 ENERGY STAR Partner of the Year – Sustained Excellence Award for continued leadership and superior contributions to ENERGY STAR. Merck has been named a Partner of the Year for 14 years in a row, and in Sustained Excellence for 12 years. ​ “Merck is committed to inventing medicines and vaccines for many of the world’s most...
Apr 18, 2019 1:00 PM ET
Merck Supports The Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)
At Merck, we aspire to improve the health and wellness of people worldwide, and to expand access to our medicines and vaccines. As part of our ongoing commitment to fighting neglected tropical diseases, Merck has announced a $500,000 grant to the World Health Organization’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)....
Dec 14, 2018 10:00 AM ET
American Chemical Society Presents Merck with Green Chemistry Challenge Award
We're proud to be named a winner of the American Chemical Society's Green Chemistry Challenge Award. The award recognizes companies for innovative processes in reducing waste and the generation of hazardous materials. Learn more about our green and sustainable science here:...
Nov 5, 2018 2:10 PM ET
Merck Named One of TIME’s 50 Genius Companies for Work in Ebola
We’re honored to be in the top 50 for TIME's 2018 Genius Companies for our work in Ebola. We are inspired every day by the work we do to make an impact on global health. Learn more about Merck's response to the Ebola outbreak.
Oct 18, 2018 3:00 PM ET

Pages

  • 3
  • 4
  • 5
  • 6